Search - tctmd.com

Displaying 21 - 40 of 128

Sort: Relevancy | Date

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT 2018

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Presenter: Felix Mahfoud, Patrick W. Serruys, Pieter C. Smits

September 25, 2018

Presentation TCT 2018

Case Presentation #2: A High-Risk, Complex Patient With STEMI and Multivessel Disease

Presenter: Anthony H. Gershlick, Pieter C. Smits, Marwan F. Jumean

September 24, 2018

Presentation TCT 2018

Flash Debate #1: Based on What We Dont Know - Culprit Lesion Only PCI With a Conservative Approach Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Deepak L. Bhatt

September 24, 2018

Presentation TCT 2018

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Thomas Engstrøm

September 24, 2018

Presentation TCT 2018

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Joo Myung Lee

September 24, 2018

Presentation TCT 2018

Management of Non-Culprit CTO in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Emmanouil S. Brilakis

September 24, 2018

Presentation TCT 2018

Rationale and Data for Multivessel PCI in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits

September 24, 2018

Presentation TCT 2018

Flash Debate: Polymeric BRS Have the Edge!

Presenter: Pieter C. Smits

September 22, 2018

Presentation TCT 2018

MVD Case Presentation With Heart Team Discussion, Case Introduction

Presenter: Antonio Colombo, Jeffrey W. Moses, Carlos Collet, Pablo Lamelas, John D. Puskas, Alfredo E. Rodriguez, Pieter C. Smits, Wilson Y. Szeto

September 22, 2018

Presentation CIT 2018

FFR Guided PCI in STEMI patients with Multivessel Disease

Presenter: Pieter C. Smits

March 23, 2018

Podcast

Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients

October 11, 2017

Presentation ACC 2017

Randomised Trial of FFR-guided Complete Revascularization versus Infarct Artery only Treatment in Multivessel STEMI Patients

Presenter: Pieter Smits

March 20, 2017

News Conference News ACC 2017

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

Todd Neale

March 18, 2017

News Conference News ACC 2017

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

Caitlin E. Cox

March 18, 2017

Presentation TCT 2016

How to Treat BRS Restenosis (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits

November 01, 2016

Presentation TCT 2016

How to Manage BRS Thrombosis (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits, Anuruck Jeamanukoolkit

November 01, 2016

Presentation TCT 2016

Identifying and Treating Benign Discontinuities From More Meaningful Intraluminal Scaffold Dismantling and Fractures (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits, Yoshinobu Onuma

November 01, 2016

Presentation TCT 2016

How to Manage BRS Stent Loss (With Case Examples)

Presenter: Ashok Seth, Pieter C. Smits, Omer Goktekin

November 01, 2016

Advertisement

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

COMPARE ABSORB: A Randomized Trial of a Polymeric Everolimus-Eluting Bioresorbable Scaffold in High-Risk and Complex Lesions

Case Presentation #2: A High-Risk, Complex Patient With STEMI and Multivessel Disease

Flash Debate #1: Based on What We Dont Know - Culprit Lesion Only PCI With a Conservative Approach Is the Preferred Strategy!

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Management of Non-Culprit CTO in STEMI

Rationale and Data for Multivessel PCI in STEMI

Flash Debate: Polymeric BRS Have the Edge!

MVD Case Presentation With Heart Team Discussion, Case Introduction

FFR Guided PCI in STEMI patients with Multivessel Disease

Episode 18: Top News of TCT 2016 Plus Anticoagulation in A-fib Patients

Randomised Trial of FFR-guided Complete Revascularization versus Infarct Artery only Treatment in Multivessel STEMI Patients

FFR-Guided Complete Revascularization Tops PCI of Culprit Artery Alone in Acute STEMI

iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions

How to Treat BRS Restenosis (With Case Examples)

How to Manage BRS Thrombosis (With Case Examples)

Identifying and Treating Benign Discontinuities From More Meaningful Intraluminal Scaffold Dismantling and Fractures (With Case Examples)

How to Manage BRS Stent Loss (With Case Examples)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content